Tea Compounds Show Surprising Power Against Cancer and Aging Proteins

Tea is the most widely consumed functional beverage on the planet, yet the molecular logic behind its celebrated health effects has remained stubbornly elusive. A new computational study published in Discover Chemistry has now mapped, in unprecedented detail, how the phytochemicals packed inside Camellia sinensis leaves might simultaneously engage multiple human proteins linked to cancer, inflammation, metabolic disease, and neurodegeneration. Using an integrated pipeline of network pharmacology, drug-likeness screening, functional enrichment, and molecular docking, the research offers one of the most systematic portraits to date of how a single plant can plausibly touch so many disease-relevant biological circuits at once.

The investigation began with a sweeping chemical census. Drawing on the IMPPAT 2.0 database, a manually curated repository built from more than 100 traditional Indian medicinal texts and over 7,000 peer-reviewed publications, the researcher retrieved 123 phytochemicals associated with Camellia sinensis. Canonical SMILES structures were cross-referenced through PubChem, and each compound was then pushed through a battery of in silico filters: admetSAR 3.0, SwissADME, the artificial intelligence-driven Deep-PK platform, and the graph-based predictor pkCSM. The gauntlet evaluated molecular weight, lipophilicity, hydrogen bonding capacity, topological polar surface area, gastrointestinal absorption, blood-brain barrier permeation, cytochrome P450 inhibition, clearance, mutagenicity, hepatotoxicity, and acute oral toxicity.

Only 14 compounds survived the full screening cascade, and their identities are telling. The list includes familiar catechins such as epicatechin and cianidanol, phenolic acids like caffeic acid and gallic acid, vitamins and cofactors including ascorbic acid and pantothenic acid, and a striking contingent of brassinosteroid-related sterols: typhasterol, teasterone, brassinolide, and castasterone, alongside the triterpenoid saponin theasapogenol B and the sapogenin A1-barrigenol. Notably, several high-profile tea polyphenols, including theasinensins and heavily galloylated derivatives, failed Lipinski’s rule of five because their sheer molecular size and polar surface area would sabotage oral bioavailability. The survivors, by contrast, showed high predicted gastrointestinal absorption, minimal interference with major CYP450 drug-metabolizing enzymes, and largely non-mutagenic, non-hepatotoxic profiles.

With the shortlist established, the study turned to target prediction. SwissTargetPrediction, a reverse-screening engine built on chemical similarity principles, assigned up to 100 putative human protein targets to each of the 14 phytochemicals, generating 1,400 raw predictions that collapsed to 262 unique proteins after deduplication. These were fed into the STRING database to construct a protein-protein interaction network of 260 nodes and 2,504 edges, with an average node degree of 19.3 and a PPI enrichment p-value below 1.0 × 10⁻¹⁶, confirming that the connectivity reflects genuine biology rather than statistical noise. Applying a stringent combined-score threshold above 0.9 retained 488 high-confidence interactions for downstream analysis.

Clustering algorithms then carved the network into eight functional modules, each a dense island of cooperating proteins. The top-scoring module, with an MCODE score of 10.824, was dominated by the PI3K/AKT and receptor tyrosine kinase machinery, including PIK3CA, AKT1 through AKT3, EGFR, ERBB2, JAK1 through JAK3, and IGF1R. Other modules captured cell cycle regulators such as CDK1, AURKA, and PLK1; GABA receptor subunits tied to neurotransmission; MAPK stress-signaling proteins; a neurodegeneration-and-apoptosis cluster featuring PSEN1, PSEN2, GSK3B, and HDAC1; cell cycle checkpoint proteins; matrix metalloproteinases involved in tissue remodeling; and cholesterol biosynthesis enzymes including HMGCR and SQLE. The breadth of these modules hints at why tea has been linked to such a bewildering variety of health benefits.

To separate the true regulatory heavyweights from peripheral players, the study applied four independent centrality algorithms in the cytoHubba plugin: Degree, Betweenness, Closeness, and Maximal Clique Centrality. Only three proteins ranked among the top ten under every single method: PIK3CA, the catalytic subunit of phosphatidylinositol-3-kinase; AKT1, the master survival kinase; and ESR1, the estrogen receptor alpha. The convergence is biologically compelling. The PI3K/AKT axis governs proliferation, apoptosis, glucose metabolism, and inflammatory signaling, and its dysregulation is a hallmark of cancer, insulin resistance, and neurodegeneration, while ESR1 sits at the intersection of hormonal signaling, neuroprotection, and breast cancer biology.

Functional annotation through the DAVID platform painted the pathways these hubs inhabit. Gene Ontology analysis linked them to apoptosis, glucose metabolic processes, insulin receptor signaling, kinase activity, and PI3K signal transduction, with cellular localization concentrated in the cytosol, plasma membrane, and lamellipodia. KEGG pathway enrichment pulled in an impressive roster of disease-relevant cascades: pathways in cancer, TNF signaling, HIF-1 signaling, AMPK signaling, FoxO signaling, VEGF signaling, estrogen signaling, Toll-like receptor signaling, prolactin signaling, and thyroid hormone signaling. A phytochemical-target-pathway network then visualized how the 14 compounds converge on AKT1, ESR1, and PIK3CA, which in turn fan out into these interconnected pathways, a textbook illustration of the multitarget, multi-pathway logic that distinguishes network pharmacology from the classical one-drug-one-target paradigm.

The structural validation stage delivered the study’s most eye-catching numbers. Using AutoDock Vina through PyRx, with docking protocols verified by re-docking co-crystallized ligands to RMSD values between 1.0 and 1.2 angstroms, several tea phytochemicals outperformed their reference inhibitors. Epicatechin and cianidanol bound AKT1 at −9.8 kcal/mol, comfortably beating the reference ligand IQO at −6.9. For the estrogen receptor ESR1, typhasterol and theasapogenol B reached −8.9 kcal/mol against OHT’s −6.5. And castasterone posted −9.7 kcal/mol against PIK3CA, far surpassing the 2Q7 reference at −6.5. Interaction maps showed the compounds engaging the same catalytic residues as the native ligands: epicatechin and cianidanol contacting Thr211, Lys268, and Val270 in AKT1; epicatechin hydrogen-bonding with Asp351 and Glu353 in ESR1; and multiple compounds anchoring to Lys802, Arg992, and Leu1028 in PIK3CA.

The authors are careful to frame these findings as hypothesis-generating rather than definitive. Docking scores estimate relative interaction strength but do not substitute for measured binding affinities, the enrichment analyses relied on unadjusted p-values vulnerable to false positives, and no ligand pose superposition or molecular dynamics simulations were performed. Experimental validation in vitro and in vivo remains the essential next step. Even so, the study provides a rigorous, systems-level rationale for centuries of empirical enthusiasm about tea, pinpointing epicatechin, cianidanol, castasterone, typhasterol, and theasapogenol B as the most promising candidates and PIK3CA, AKT1, and ESR1 as the molecular crossroads where a humble cup of tea may exert its most consequential effects.

Subject of Research: Multitarget therapeutic potential of Camellia sinensis phytochemicals analyzed by network pharmacology and molecular docking

Article Title: Elucidating the multitarget therapeutic potential of Camellia sinensis (Tea) phytochemicals using network pharmacology, functional annotation, and molecular docking

Article References: Hossain, M. M. (2026). Elucidating the multitarget therapeutic potential of Camellia sinensis (Tea) phytochemicals using network pharmacology, functional annotation, and molecular docking. Discover Chemistry, 3(1), Article 541. https://doi.org/10.1007/s44371-026-01000-0

Image Credits: AI Generated

DOI: 10.1007/s44371-026-01000-0

Keywords: Camellia sinensis, tea, network pharmacology, molecular docking, phytochemicals, PIK3CA, AKT1, ESR1, ADMET, drug discovery, cancer, molecular targets